283 related articles for article (PubMed ID: 27354656)
1. Antihypertensive Medication Use in Older Patients Transitioning from Chronic Kidney Disease to End-Stage Renal Disease on Dialysis.
Chang TI; Zheng Y; Montez-Rath ME; Winkelmayer WC
Clin J Am Soc Nephrol; 2016 Aug; 11(8):1401-1412. PubMed ID: 27354656
[TBL] [Abstract][Full Text] [Related]
2. Use of Antihypertensive Agents and Association With Risk of Adverse Outcomes in Chronic Kidney Disease: Focus on Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.
Ku E; McCulloch CE; Vittinghoff E; Lin F; Johansen KL
J Am Heart Assoc; 2018 Oct; 7(19):e009992. PubMed ID: 30371331
[TBL] [Abstract][Full Text] [Related]
3. DOPPS data suggest a possible survival benefit of renin angiotensin-aldosterone system inhibitors and other antihypertensive medications for hemodialysis patients.
Karaboyas A; Xu H; Morgenstern H; Locatelli F; Jadoul M; Nitta K; Dasgupta I; Tentori F; Port FK; Robinson BM
Kidney Int; 2018 Sep; 94(3):589-598. PubMed ID: 29908836
[TBL] [Abstract][Full Text] [Related]
4. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
5. Add-On Antihypertensive Medications to Angiotensin-Aldosterone System Blockers in Diabetes: A Comparative Effectiveness Study.
Schroeder EB; Chonchol M; Shetterly SM; Powers JD; Adams JL; Schmittdiel JA; Nichols GA; O'Connor PJ; Steiner JF
Clin J Am Soc Nephrol; 2018 May; 13(5):727-734. PubMed ID: 29572286
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients.
Griffith TF; Chua BS; Allen AS; Klassen PS; Reddan DN; Szczech LA
Am J Kidney Dis; 2003 Dec; 42(6):1260-9. PubMed ID: 14655199
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis.
Wu HY; Huang JW; Lin HJ; Liao WC; Peng YS; Hung KY; Wu KD; Tu YK; Chien KL
BMJ; 2013 Oct; 347():f6008. PubMed ID: 24157497
[TBL] [Abstract][Full Text] [Related]
8. Management of Heart Failure Patient with CKD.
Banerjee D; Rosano G; Herzog CA
Clin J Am Soc Nephrol; 2021 Jul; 16(7):1131-1139. PubMed ID: 33495289
[TBL] [Abstract][Full Text] [Related]
9. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
[TBL] [Abstract][Full Text] [Related]
10. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
Fang G; Annis IE; Farley JF; Mahendraratnam N; Hickson RP; Stürmer T; Robinson JG
Pharmacotherapy; 2018 Jan; 38(1):29-41. PubMed ID: 29059475
[TBL] [Abstract][Full Text] [Related]
11. Assessing Guideline-Directed Medication Therapy for Heart Failure in End-Stage Renal Disease.
Cutshall BT; Duhart BT; Saikumar J; Samarin M; Hutchison L; Hudson JQ
Am J Med Sci; 2018 Mar; 355(3):247-251. PubMed ID: 29549927
[TBL] [Abstract][Full Text] [Related]
12. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
13. Hypertension Management in Transition: From CKD to ESRD.
Valika A; Peixoto AJ
Adv Chronic Kidney Dis; 2016 Jul; 23(4):255-61. PubMed ID: 27324679
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive medications and risk of death and hospitalizations in US hemodialysis patients: Evidence from a cohort study to inform hypertension treatment practices.
Shafi T; Sozio SM; Luly J; Bandeen-Roche KJ; St Peter WL; Ephraim PL; McDermott A; Herzog CA; Crews DC; Scialla JJ; Tangri N; Miskulin DC; Michels WM; Jaar BG; Zager PG; Meyer KB; Wu AW; Boulware LE;
Medicine (Baltimore); 2017 Feb; 96(5):e5924. PubMed ID: 28151871
[TBL] [Abstract][Full Text] [Related]
15. Geographic variation in cardioprotective antihypertensive medication usage in dialysis patients.
Wetmore JB; Mahnken JD; Mukhopadhyay P; Hou Q; Ellerbeck EF; Rigler SK; Spertus JA; Shireman TI
Am J Kidney Dis; 2011 Jul; 58(1):73-83. PubMed ID: 21621889
[TBL] [Abstract][Full Text] [Related]
16. Relationship Between Patterns in Antihypertensive Drugs Medication and Mortality in Incident Dialysis Patients: A Multicenter Prospective Cohort Study.
Fujii M; Inaguma D; Koide S; Ito E; Takahashi K; Hayashi H; Tsuboi N; Hasegawa M; Yuzawa Y
Ther Apher Dial; 2019 Aug; 23(4):353-361. PubMed ID: 30565866
[TBL] [Abstract][Full Text] [Related]
17. Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used?
Silvariño R; Rios P; Baldovinos G; Chichet MA; Perg N; Sola L; Saona G; De Souza N; Lamadrid V; Gadola L
Nephron; 2019; 143(2):100-107. PubMed ID: 31203280
[TBL] [Abstract][Full Text] [Related]
18. Cochrane in context: pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
[TBL] [Abstract][Full Text] [Related]
20. Lab monitoring and acute care utilization during initiation of renin angiotensin aldosterone inhibitors or diuretics in chronic kidney disease.
Garlo KG; Bates DW; Seger DL; Fiskio JM; Charytan DM
Medicine (Baltimore); 2019 Dec; 98(49):e17963. PubMed ID: 31804307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
